1.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

2.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

3.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

4.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

5.

Evolution of educational inequalities in site-specific cancer mortality among Belgian men between the 1990s and 2000s using a “fundamental cause” perspective

1.

Linkage Analysis in a Dutch Population Isolate Shows No Major Gene for Left-Handedness or Atypical Language Lateralization

2.

Linkage Analysis in a Dutch Population Isolate Shows No Major Gene for Left-Handedness or Atypical Language Lateralization

3.

Linkage Analysis in a Dutch Population Isolate Shows No Major Gene for Left-Handedness or Atypical Language Lateralization

4.

Linkage Analysis in a Dutch Population Isolate Shows No Major Gene for Left-Handedness or Atypical Language Lateralization

5.

Linkage Analysis in a Dutch Population Isolate Shows No Major Gene for Left-Handedness or Atypical Language Lateralization

1.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

2.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

3.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

4.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

5.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

6.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

7.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

8.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

1.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

2.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

3.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

4.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

5.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

6.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

7.

Instauration et optimisation d'une insulinothérapie en médecine générale : InsuStar, une étude observationnelle prospective belge dans le diabète de type 2 ; Initiating and intensi...

1.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

2.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

3.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

4.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

5.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

6.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

7.

Vitamin D inadequacy in Belgian postmenopausal osteoporotic women.

1.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

2.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

3.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

4.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

5.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

6.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

7.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency.

1.

Insuline detemir (Levemir) dans l'etude predictive: resultats obtenus chez les patients diabetiques de type 1 de la cohorte belge. ; Insulin detemir in the predictive study: result...

2.

Insuline detemir (Levemir) dans l'etude predictive: resultats obtenus chez les patients diabetiques de type 1 de la cohorte belge. ; Insulin detemir in the predictive study: result...

3.

Insuline detemir (Levemir) dans l'etude predictive: resultats obtenus chez les patients diabetiques de type 1 de la cohorte belge. ; Insulin detemir in the predictive study: result...

4.

Insuline detemir (Levemir) dans l'etude predictive: resultats obtenus chez les patients diabetiques de type 1 de la cohorte belge. ; Insulin detemir in the predictive study: result...

1.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

2.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

3.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

4.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

5.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

6.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

7.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

1.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

2.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

3.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

4.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

5.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

6.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

7.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

8.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

9.

Health literacy among asthma patients and treatment expectations: results of a Belgian survey.

1.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

2.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

3.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

4.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

5.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

6.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

7.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.